mRNA & Lipid-based Formulations
If mRNA therapies are at the heart of your science, you'll be able to capitalize on our lipid-based formulation development and manufacturing capabilities for mRNA, as well as other active pharmaceutical ingredients (APIs) requiring lipid encapsulation.
For over 20 years, we have been working with lipid-based formulations. We have decades of expertise in manufacturing complex API formulations, and we currently support the development, tech transfer, manufacturing, and fill/finish of liposomes and lipid nanoparticles (LNP), including LNP-mRNA.
Our foundational infrastructure and capabilities allow us to support out clients' needs from early phase to commercial scale LNP-mRNA and other API lipid-based formulations and fill/finish.